GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
85 hedge funds and large institutions have $45M invested in GALENA BIOPHARMA INC COM in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 17 closing their positions.
6% less funds holding
Funds holding: 90 → 85 (-5)
11% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 27
12% less call options, than puts
Call options by funds: $5.8M | Put options by funds: $6.56M
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
35% less capital invested
Capital invested by funds: $68.9M → $45M (-$23.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$305K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$267K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$258K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$248K |
| 5 |
State Street
Boston,
Massachusetts
|
+$172K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.65M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$1.18M |
| 3 |
D.E. Shaw & Co
New York
|
-$468K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$242K |
| 5 |
LPL Financial
San Diego,
California
|
-$155K |
RXII Hedge Fund Activity: Q3 2014 in Review
85 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q3 2014, worth a combined $45M — down 35% from $68.9M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of RXII and 14 opened new positions — a net loss of 3 holders — while 27 trimmed existing stakes and 24 added.
The largest buyer was Morgan Stanley, adding an estimated $305K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $1.65M sold.
- 85 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q3 2014, down from 90 in Q2 2014.
- Funds reported $45M of GALENA BIOPHARMA INC COM stock for Q3 2014, down 35% quarter-over-quarter.
- 14 funds opened new GALENA BIOPHARMA INC COM positions in Q3 2014 and 17 closed out, a net change of -3 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q3 2014 was Morgan Stanley, an estimated $305K added.
- The largest GALENA BIOPHARMA INC COM seller in Q3 2014 was Bridgeway Capital Management, an estimated $1.65M sold.
Based on aggregated 13F filings for Q3 2014.